Stock Fundamentals

Company Information

Company Name
Repligen Corporation
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
ISIN: US7599161095
CIK: 0000730272
CUSIP: 759916109
Currency: USD
Full Time Employees: 2,000
Phone: 781 250 0111
Fiscal Year End: December
IPO Date: Mar 26, 1990
Description:

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Address:

Building 1, Waltham, MA, United States, 02453

Directors & Officers

Name Title Year Born
Mr. Olivier Loeillot President, CEO & Director 1970
Mr. Jason K. Garland CFO & Chief Compliance Officer 1974
Mr. James R. Bylund Chief Operating Officer 1964
Mr. Anthony J. Hunt Advisor 1964
Mr. Ralf Kuriyel Senior Vice President of Research & Development 1958
Mr. Brian Douglass Senior VP & Chief Product Officer 1975
Ms. Violetta Hughes Chief Accounting Officer 1973
Mr. Jacob K. Johnson C.F.A. Vice President of Investor Relations NA
Mr. George A Scott Jr., J.D., M.B.A. Senior VP & General Counsel NA
Mr. Neil Whitfield Senior Vice President of Sales NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 17, 2025 Karen A Dawes N/A Sale 275.00 $161.00 $44.28K
Nov 18, 2025 James Bylund N/A Sale 2.19K $151.21 $331.30K
Nov 18, 2025 James Bylund N/A Sale 2.19K $151.21 $331.30K
Nov 13, 2025 Anthony Hunt N/A Sale 20.00K $154.61 $3.09M
Nov 12, 2025 Anthony Hunt N/A Sale 25.00K $156.88 $3.92M
Oct 31, 2025 Lisa C. McClain N/A Sale N/A $149.06 N/A
Oct 30, 2025 Lisa C. McClain N/A Sale N/A $144.57 N/A
Oct 30, 2025 Lisa C. McClain N/A Purchase N/A $144.57 N/A
Aug 08, 2025 Martin D Madaus N/A Purchase 1.80K $112.13 $201.83K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 5.99M Mar 31, 2026 10.62% $0.01 -9.46%
Vanguard Group Inc 4.99M Dec 31, 2025 8.85% $0.01 -1.00%
T. Rowe Price Associates, Inc. 4.88M Mar 31, 2026 8.65% $0.07 6.07%
FMR Inc 2.89M Mar 31, 2026 5.12% $0.02 0.66%
United Capital Financial Advisers Inc 2.77M Mar 31, 2026 4.92% $2.01 0.11%
Vanguard Capital Management, LLC 2.40M Mar 31, 2026 4.25% $0.01 0.00%
Vanguard Portfolio Management, LLC 2.31M Mar 31, 2026 4.09% $0.01 0.00%
State Street Corp 1.78M Mar 31, 2026 3.15% $0.01 3.39%
Bank of New York Mellon Corp 1.53M Mar 31, 2026 2.71% $0.03 13.88%
Maverick Capital Ltd 1.52M Mar 31, 2026 2.69% $2.06 0.00%
Massachusetts Financial Services Company 1.40M Mar 31, 2026 2.48% $0.06 14.97%
T. Rowe Price Investment Management,Inc. 1.37M Mar 31, 2026 2.42% $0.11 98.21%
Amvescap Plc. 1.28M Mar 31, 2026 2.27% $0.02 1.74%
Wasatch Advisors LP 1.24M Mar 31, 2026 2.20% $0.97 0.00%
RTW INVESTMENTS, LLC 1.21M Mar 31, 2026 2.14% $1.41 13.35%
Franklin Resources Inc 1.19M Mar 31, 2026 2.12% $0.03 8.32%
Citadel Advisors Llc 1.10M Mar 31, 2026 1.95% $0.02 -21.16%
Conestoga Capital Advisors, LLC 1.10M Mar 31, 2026 1.95% $2.58 3.76%
Geode Capital Management, LLC 1.06M Mar 31, 2026 1.89% $0.01 3.36%
Ameriprise Financial Inc 925.21K Mar 31, 2026 1.64% $0.03 87.21%

Shares Statistics

Shares Outstanding: 56.41M
Shares Float: 53.36M
% Insiders: 524.70%
% Institutions: 11,967.10%
Short % Float: 10.60%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 1.80M 3.18% ▲ 0.02% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.71M 3.04% ▲ 0.26% Apr 30, 2026
3 US Small-Cap Growth II Equity Comp 1.26M 2.23% ▲ 34.10% Mar 31, 2026
4 Vanguard Small Cap Index 1.23M 2.19% ▼ 0.19% Apr 30, 2026
5 T. Rowe Price New Horizons 1.23M 2.18% ▼ 1.93% Apr 30, 2026
6 MFS Mid Cap Growth A 862.37K 1.53% ▲ 0.00% Apr 30, 2026
7 MFS Mid Cap Growth Equity 862.37K 1.53% ▲ 4.79% Mar 31, 2026
8 T. Rowe Price US All-Cap Opp Eq Comp 748.46K 1.33% ▲ 0.00% Mar 31, 2026
9 Vanguard Small Cap Growth Index Inv 691.03K 1.23% ▼ 0.09% Apr 30, 2026
10 BlackRock Mid-Cap Growth Equity Instl 662.94K 1.18% ▼ 3.80% Apr 30, 2026

Valuation Metrics

Enterprise Value: $7.27B
Trailing P/E: 143.51
Forward P/E: 66.23

Financial Highlights

Market Cap: $7.37B
EBITDA: $134.24M
P/E Ratio: $143.51
PEG Ratio: $2.06
Book Value: $37.33
Earnings/Share: $0.91
Profit Margin: 6.73%
Operating Margin: 8.90%
ROA (TTM): 1.18%
ROE (TTM): 2.51%
Revenue (TTM): $763.34M
Revenue/Share (TTM): $13.56
Earnings Growth (YOY): 47.90%
Revenue Growth (YOY): 14.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 8.37x 0.27x 0.29x 2.57x 3.43x
2024-12-31 8.41x 0.27x 0.30x -1.56x 6.74x
2023-12-31 7.02x 0.30x 0.30x 5.44x 4.71x
2022-12-31 2.47x 0.15x 0.25x 75.47x 1.05x
2021-12-31 2.48x 0.15x 0.26x 13.15x 1.30x
2020-12-31 2.83x 0.16x 0.20x 6.70x 2.53x
2019-12-31 13.28x 0.22x 0.24x 4.31x 4.20x
2018-12-31 2.12x 0.17x 1.14x 3.87x 2.48x
2017-12-31 9.63x -6.30x 1.26x 2.17x 8.22x
2016-12-31 8.74x 1.13x 0.42x 4.24x 7.76x
2015-12-31 5.50x 0.00x 0.16x 430.13x 0.00x
2014-12-31 7.58x 0.00x -0.25x 214.01x 0.00x
2013-12-31 7.64x 0.00x 0.12x 458.85x 0.00x
2012-12-31 6.16x 0.00x 0.13x 195.42x 0.00x
2011-12-31 6.25x 0.00x 0.13x N/A 0.00x
2010-12-31 12.08x 0.00x 0.07x -14.30x 0.00x
2009-12-31 12.81x 0.00x 0.07x -2,924.28x 0.00x
2008-12-31 12.04x 0.00x 0.07x 1,309.48x 0.00x
2007-12-31 11.86x 0.00x 0.07x 12,113.34x 0.01x
2006-12-31 7.71x 0.03x 0.16x -2.05x 0.05x
2005-12-31 7.33x 0.01x 0.12x -1.75x -0.10x
2004-12-31 5.90x 0.00x 0.11x -1.39x -0.02x
2003-12-31 6.58x 0.00x 0.11x -1.04x 0.00x
2002-12-31 4.92x 0.00x 0.08x -1.12x 0.00x
2001-12-31 8.72x 0.00x 0.08x -1.25x 0.00x
2000-12-31 20.41x 0.00x 0.08x -1.39x 0.00x
1999-12-31 29.80x 0.00x 0.03x -1.02x 0.00x
1998-12-31 7.50x 0.00x 0.23x -0.60x 0.00x
1997-12-31 12.50x 0.00x 0.07x -1.00x 0.00x
1996-12-31 19.67x 0.00x 0.04x -1.00x 0.00x
1995-12-31 5.88x 0.94x 0.14x -0.24x -1.64x
1994-12-31 1.57x 0.00x 0.50x N/A 0.00x
1993-12-31 2.33x 0.16x 0.31x -0.98x -0.26x
1992-12-31 3.62x 0.13x 0.26x -1.00x -0.27x
1991-12-31 5.18x 0.05x 0.13x -1.00x -0.28x
1990-12-31 15.18x 0.05x 0.05x -1.46x -0.23x
1989-12-31 10.19x 0.00x 0.07x -1.04x 0.00x
1988-12-31 4.07x 0.00x 0.14x -1.03x 0.00x
1987-12-31 4.00x 0.00x 0.10x -3.67x 0.00x
1986-12-31 12.00x 0.00x 0.11x -0.24x 0.00x
1985-12-31 7.10x 0.00x 0.17x -1.79x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RGEN.US!